Clinical Trials Browser

Phase 1/2 × Active not recruiting × Uveal Melanoma × Clear all

NCT06784648 2025-11-19

Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma

Phase 1/2 Active not recruiting

Uveal Melanoma, Melanoma, Neoplasm Metastasis

NCT04283890 2025-09-09

CHOPIN

Phase 1/2 Active not recruiting

Uveal Melanoma, Neoplasm Metastasis

NCT05415072 2025-07-20

A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas

Phase 1/2 Active not recruiting

Uveal Melanoma, Eye Neoplasms, Melanoma, Neoplasms